Official Publications Gilead Sciences, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 03:57:06 2024-06-10 pm EDT			5-day change	1st Jan Change
65.25 ^USD	+0.85%		+2.57%	-19.69%

05:16pm	Arcus Completes Enrollment in Phase 3 Trial of Domvanalimab-Containing Regimen for Stomach Cancer	MT
Jun. 06	Gilead Says Bulevirtide With PegIFN Data 'Superior' to Bulevirtide Monotherapy; Achieves 46% Rate of Undetectable HDV RNA	MT

SEC Filing 8K	May. 08	CO
SEC Filing 4K	May. 08	CO
SEC Filing 10Q-1	May. 07	CO
SEC Filing 4K	May. 07	CO
SEC Filing 4K	May. 06	CO
SEC Filing 4K	Apr. 25	CO
Slide show Q1	Apr. 24	CO
1st quarter results	Apr. 24	CO
SEC Filing 8K	Apr. 24	CO
Mixed general shareholder meeting	Mar. 27	CO
Proxy Statments	Mar. 17	CO
SEC Filing 4K	Feb. 28	CO
SEC Filing 10K	Feb. 22	CO
SEC Filing 4K	Feb. 12	CO
SEC Filing 8K	Feb. 11	CO
SEC Filing 8K	Feb. 05	CO
Slide show results	Feb. 05	CO
Annual results	Feb. 05	CO
SEC Filing 8K	Jan. 31	CO
Changes in management and corporate officers	Jan. 31	CO
SEC Filing 13G	Jan. 30	CO
SEC Filing 4K	Dec. 10	CO
SEC Filing 4K	Nov. 12	CO
SEC Filing 8K	Nov. 06	CO
SEC Filing 10Q-3	Nov. 06	CO